Products
Platform
Research
Market
Learn
Partner
Support
IPO

V

Valiant Laboratories IPO

₹14,700 / 105 shares

Issue Date

--

Price Range

₹140

Lot Size

105

IPO Size

₹152.46 Cr

Valiant Laboratories IPO Listing Details

Listing On

6 Oct'23

Issue Price

--

Listed Price

₹ 162.15

Retail Gain/Listing Gain

15.82%

Schedule of Valiant Laboratories IPO

Start date

End date

Allotment of bids

Refund Initiation

Listing on exchange

06/10/2023

Valiant Laboratories Limited is an active pharmaceutical ingredient (API)/bulk drug manufacturing company, with a focus on manufacturing Paracetamol. Bulk drugs/APIs serve as raw materials for manufacturing finished dosage forms or formulations.

India is the largest provider of generic drugs, globally contributing to approximately 20% of global supply by volume of generic drugs. The overall API industry in India grew from Rs. 781 billion in fiscal 2017 to Rs. 1,179 billion in fiscal 2022, registering a CAGR of 8.5% in rupee terms. Going forward, the API industry is expected to grow at a rate of 9-11% between fiscal 2022 and 2027, largely driven by the increase in API exports. More specifically, the paracetamol API industry (domestic + exports) grew from Rs. 22 billion in fiscal 2017 to Rs. 39 billion in fiscal 2023.

Read More
  • Any changes to the paracetamol API industry or the company’s product demand will adversely affect revenues, financials and profitability.
  • The company is dependent on a single manufacturing facility.
  • The company must always be subject to strict quality requirements, regular inspections and audits.
  • Diversification into new chemistries.
  • Increase penetration into international markets including regulated markets.
  • Improve operational efficiencies through backward integration of the proposed facility.
Loading chart...
Here's a video playlist to help you invest in the upcoming Valiant Laboratories Limited IPO
How to apply for IPO through ASBA

Kotak Neo

00m 59s

Apply for Valiant Laboratories IPO